<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362949">
  <stage>Registered</stage>
  <submitdate>27/08/2012</submitdate>
  <approvaldate>5/09/2012</approvaldate>
  <actrnumber>ACTRN12612000953831</actrnumber>
  <trial_identification>
    <studytitle>Can Heart Rate Variability analysis reduce analgesic requirements after laparoscopic cholecystectomy?</studytitle>
    <scientifictitle>A randomised controlled pilot trial comparing the effectiveness of intraoperative Acute Nociception Index (ANI) monitoring on reducing moderate-severe pain in the Postanaesthesia Care Unit (PACU) in patients having elective cholecystectomy.</scientifictitle>
    <utrn>U1111-1133-8409</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>cholecystectomy</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Dose of intraoperative intravenous analgesia administration (morphine or fentanyl) based on measurement of autonomic tone using the Acute Nociception Index (ANI) monitor. The ANI monitor is a modified ECG monitor that uses a software algorthim to measure variation in the ECG R-R interval to generate an index for the patients autonomic tone. Dose ranges MORPHINE 3-5mg (give 5mg if ANI &lt; 30), max cumulative dose 40mg (age&lt;50), 30mg (age&lt;75) OR FENTANYL 30-50mcg (give 50mcg if ANI &lt; 30), max cumulative dose 400mcg (age&lt;50), 300mcg (age&lt;75)
Review ANI after 5 minutes and repeat bolus as  above if ANI score remains below 50. Repeat after every 5 minutes until ANI score &gt;50 (maximum morphine dose permitted 40mg if age&lt;50, 30 mg if age 50-75- or fentanyl equivalent)</interventions>
    <comparator>Intervention group:,  ANI score  below 50: 
a.	MORPHINE 3-5mg (give 5mg if ANI &lt; 30), max cumulative dose 40mg (age&lt;50), 30mg (age&lt;75)
OR
b.	FENTANYL 30-50mcg (give 50mcg if ANI &lt; 30), max cumulative dose 400mcg (age&lt;50), 300mcg (age&lt;75)
Review ANI every 5 minutes and bolus as per above.
Comparator group: usual practice. i.e. Intraoperative analgesia administration (morphine of fentanyl) in doses based on clinician experience and training, based on usual clinical practice (e.g. increase heart rate,increased  blood pressure, etc). There are no protocols to guide this. Maximum doses as above.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Proportion with severe pain (Visual Analogue Scale &gt;5 ) in PACU</outcome>
      <timepoint>1 hour</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Sum of pain scores (Visual Analogue Scale) at 15, 30, 45 and 60 minutes in recovery room</outcome>
      <timepoint>1 hour</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Total amount of rescue Morphine/Fentanyl protocol in PACU in mg. PACU opioid pain protocol is based on clinical assessment of patients pain i.e VAS score 3-5 give morphine 1mg, reassess after 5 minutes, VAS pain score &gt;5 give 3mg morphine, reassess after 5 minutes.</outcome>
      <timepoint>1 hour</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Elective laparoscopic cholecystectomy</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>74</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Inability to obtain informed consent from patient
Cognitively impaired patients
Emergency cholecystectomy
Non-sinus rhythmn cardiac status
Known impairment of the autonomic nervous system
Pregnancy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Eligible participant will be identified from the elective surgical operating list. Informed written consent will be sought from the patient on the day of surgery by an investigator, or by the anaesthetist / anaesthetic registrar.
Randomisation to a treatment group will be determined in advance (blocked random allocation) and concealed by means of sealed, opaque and tamper-proof envelopes.</concealment>
    <sequence>Blocked random allocation by the trial statistician</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/10/2012</anticipatedstartdate>
    <actualstartdate>1/10/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate>9/09/2013</actualenddate>
    <samplesize>100</samplesize>
    <actualsamplesize>120</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Peninsula Health (Frankston Hospital)</primarysponsorname>
    <primarysponsoraddress>Hastings Rd
Frankston VIC  3199</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Peninsula Health</fundingname>
      <fundingaddress>Hastings Rd
Frankston. VIC 3199</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study investigates whether using a new pain monitoring device, the ANI monitor, can better predict how much pain-killing medication patients having keyhole gallbladder surgery  need. During gallbladder removal patients are asleep and unaware but still need pain-killing medication such as morphine or fentanyl to make sure they are not in severe pain when you wake up.

Anaesthetist currently estimate how much pain-killing medication is needed based on factors including patient age, body weight, thepatients response to the surgery judged by blood pressure/heart rate monitoring and the anaesthetists clinical experience. Using these methods, patients sometimes wake up after surgery with severe pain because the prediction of dose for pain-killing medicine during surgery was incorrect.

In this study, we will be testing a new pain monitor which may be able to more accurately predict a patients analgesia requirements during surgery. This monitor requires two gel electrodes to be placed on your chest, alongside the gel electrodes that are put on by the anaesthetist for standard heart monitoring. It records  heart rate with great accuracy and using complex mathematical formulas, generates a number (the acute nociception index) which may better predict the pain levels while the patient is anaesthetized. 
This study compares the comfort of patients waking up after gallbladder surgery when the monitor is used compared with standard care.</summary>
    <trialwebsite />
    <publication>J. A. Szental, A. Webb, C. Weeraratne, A. Campbell, H. Sivakumar, and S. Leong
Postoperative pain after laparoscopic cholecystectomy is not reduced by intraoperative analgesia guided by analgesia nociception index (ANIÂ®) monitoring: a randomized clinical trial
Br. J. Anaesth. (2015) 114 (4): 640-645 first published online December 23, 2014 doi:10.1093/bja/aeu411</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Peninsula Health HREC</ethicname>
      <ethicaddress>PO Box 52
Frankston VIC 3199</ethicaddress>
      <ethicapprovaldate>3/09/2012</ethicapprovaldate>
      <hrec>HREC/12/PH/65</hrec>
      <ethicsubmitdate>22/08/2012</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dr Ashley Webb</name>
      <address>Department of Anaesthesia
Peninsula Health
Hastings Rd
Frankston VIC 3199</address>
      <phone>+61397847445</phone>
      <fax>+61397847441</fax>
      <email>awebb@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr Ashley Webb</name>
      <address>Department of Anaesthesia
Peninsula Health
Hastings Rd
Frankston VIC 3199</address>
      <phone>+61397847445</phone>
      <fax>+61397847441</fax>
      <email>awebb@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Ashley Webb</name>
      <address>Department of Anaesthesia
Peninsula Health
Hastings Rd
Frankston VIC 3199</address>
      <phone>+61397847445</phone>
      <fax />
      <email>awebb@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Joshua Szental</name>
      <address>Department of Anaesthesia
Peninsula Health
Frankston VIC 3199</address>
      <phone>+61397847445</phone>
      <fax />
      <email>jszental@gmail.com</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>